At the American Heart Association Meeting You Really Can't Escape The New Cholesterol Drugs

There’s no escaping them. At the American Heart Association in Chicago going on right now  Amgen and Sanofi/Regeneron, which are developing competing cholesterol lowering drugs known as PCSK9 inhibitors, have mounted a full scale attack to capture the eyeballs and the brains of cardiologists and any other innocent bystanders who happen to be at the McCormick convention center.
Source: Technology